XEOMIN® (incobotulinumtoxinA) – Essential Safety Information for Consumers

XEOMIN (incobotulinumtoxinA) may cause serious and potentially life-threatening side effects in rare cases. Some individuals may experience difficulty swallowing, speaking, or breathing within hours or even weeks after injection if the muscles responsible for these functions become weakened. In severe situations, complications from swallowing or breathing issues could lead to death. People with pre-existing respiratory conditions may rely on neck muscles for breathing and are therefore at a higher risk. In certain cases, swallowing difficulties can persist for months, requiring a feeding tube to maintain proper nutrition and hydration. If these issues become severe, food or liquids may accidentally enter the lungs, further increasing the risk of complications.

Additionally, Xeomin injection may sometimes cause the spread of toxin effects beyond the injection area, leading to symptoms resembling botulism. These can include muscle weakness throughout the body, blurred or double vision, drooping eyelids, slurred speech, hoarseness, loss of bladder control, or difficulty breathing and swallowing. These symptoms may develop hours or even weeks after treatment, so patients should remain cautious and avoid driving or operating machinery until they know how Xeomin Botox affects them.

what Is Xeomin – Xeomin Injections

Xeomin injections (incobotulinumtoxinA) by Merz Pharmaceuticals are FDA-approved to treat cervical dystonia, blepharospasm, and moderate to severe frown lines between the eyebrows in adults. This non-surgical wrinkle treatment blocks nerve signals in targeted muscles, temporarily relaxing them for smoother, more youthful results.

Xeomin is a prescription injectable medication used for various medical and aesthetic conditions:

• Salivary gland treatment: Injected into saliva-producing glands to help manage persistent drooling (chronic sialorrhea) in adults and children aged 2 years and older.
• Muscle stiffness management: Administered into targeted muscles to reduce upper limb spasticity (increased muscle tightness) in adults.
• Pediatric use: Helps alleviate arm muscle stiffness in children aged 2 to 17 years, excluding cases linked to cerebral palsy.
• Neck muscle treatment: Used in adults to relieve abnormal head posture and neck discomfort caused by cervical dystonia (CD).
• Eye muscle relaxation: Treats uncontrolled eyelid spasms (blepharospasm) in adults for smoother eye movement and comfort.

Safety Notice: The safety and effectiveness of Xeomin Botox procedures have not been confirmed in children under 2 years old for drooling or upper limb stiffness, or in individuals under 18 years old for cervical dystonia or blepharospasm.